Legal & General Group Plc Boosts Position in Cigna Group $CI

Legal & General Group Plc increased its stake in Cigna Group (NYSE:CI) by 1.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,036,852 shares of the health services provider’s stock after acquiring an additional 26,175 shares during the quarter. Legal & General Group Plc’s holdings in Cigna Group were worth $560,603,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. OLD National Bancorp IN increased its stake in Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after buying an additional 37 shares during the period. Physician Wealth Advisors Inc. grew its holdings in Cigna Group by 1.5% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock worth $782,000 after acquiring an additional 41 shares in the last quarter. Cookson Peirce & Co. Inc. grew its holdings in Cigna Group by 0.8% during the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after acquiring an additional 41 shares in the last quarter. Signet Financial Management LLC grew its holdings in Cigna Group by 0.6% during the 3rd quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock worth $2,150,000 after acquiring an additional 41 shares in the last quarter. Finally, Palumbo Wealth Management LLC grew its holdings in Cigna Group by 2.3% during the 3rd quarter. Palumbo Wealth Management LLC now owns 1,927 shares of the health services provider’s stock worth $524,000 after acquiring an additional 43 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity

In other news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 205,904 shares of company stock worth $60,277,068. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on CI. Wells Fargo & Company increased their target price on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. Leerink Partners increased their target price on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a report on Friday, February 6th. Robert W. Baird set a $337.00 target price on shares of Cigna Group in a report on Friday, May 1st. Mizuho set a $330.00 target price on shares of Cigna Group in a report on Friday, May 1st. Finally, The Goldman Sachs Group increased their target price on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.80.

Cigna Group Stock Down 0.1%

NYSE:CI opened at $286.06 on Tuesday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The stock has a market capitalization of $75.67 billion, a P/E ratio of 12.13, a P/E/G ratio of 1.00 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company’s 50-day simple moving average is $277.02 and its 200-day simple moving average is $276.37.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same period last year, the business earned $6.74 EPS. The company’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.